Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc.
Certiorari Denied
Petition for certiorari denied on January 13, 2020.
Issue
Whether patents that claim a method of medically treating a patient automatically satisfy Section 101 of the Patent Act, even if they apply a natural law using only routine and conventional steps. CVSG 12/6/2019.
Oct 26, 2018Application (18A461) to extend the time to file a petition for a writ of certiorari from November 12, 2018 to December 27, 2018, submitted to The Chief Justice.
Oct 31, 2018Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018.
Dec 27, 2018Petition for a writ of certiorari filed. (Response due January 28, 2019)Jan 22, 2019Motion to extend the time to file a response from January 28, 2019 to February 12, 2019, submitted to The Clerk.Jan 23, 2019Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019.
Jan 28, 2019Brief amici curiae of Intellectual Property and Innovation Professors, Engine Advocacy, et al. filed.Jan 28, 2019Brief amici curiae of The Association for Accessible Medicines and Certain Individual Companies filed.Feb 12, 2019Brief of respondent Vanda Pharmaceuticals USA, Inc. in opposition filed.Feb 26, 2019Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed.Feb 27, 2019DISTRIBUTED for Conference of 3/15/2019.
Mar 15, 2019Letter of Hikma Pharmaceuticals USA Inc., et al. received.Mar 18, 2019The Solicitor General is invited to file a brief in this case expressing the views of the United States.
May 22, 2019Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda Pharmaceuticals Inc.Dec 6, 2019Brief amicus curiae of United States filed.Dec 20, 2019Supplemental brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed.Dec 23, 2019DISTRIBUTED for Conference of 1/10/2020.
Dec 23, 2019Supplemental brief of respondent Vanda Pharmaceuticals USA, Inc. filed. (Distributed)Dec 26, 2019Letter of December 26, 2019 from counsel for petitioner received. (Distributed)Jan 13, 2020Petition DENIED.
Recommended Citation: Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc., SCOTUSblog, https://www.scotusblog.com/cases/hikma-pharmaceuticals-usa-inc-v-vanda-pharmaceuticals-inc/